• 作者：Sandra Herranz Antol&#237 ; n^a ; ^{herranzantolin@yahoo.es} ; Mar&#237 ; a del Carmen Garc&#237 ; a Mart&#237 ; nez^b ; Visitació ; n Á ; lvarez De Frutos^a
• 关键词：Deficiencia de vitamina D ; Obesidad mó ; rbida ; Calcidiol
• 刊名：Endocrinolog铆a y Nutrici贸n
• 出版年：2010
• 期刊代码：pca151_15750922
• 类别：med
• 出版时间：June-July 2010
• 卷：57
• 期：6
• 页码：256-261
• 文件大小：195 K

Objectives

Recent studies show a high prevalence of vitamin D deficiency in the general population, especially in the elderly. There are also studies reporting the same observations in the morbidly obese, although few of these studies have compared morbidly obese individuals with non-obese persons. The objectives of this study were to estimate the prevalence of vitamin D deficiency and secondary hyperparathyroidism in both groups and to assess whether there is a relationship between obesity and vitamin D deficiency.

Methods

This study was carried out in 138 patients in the Guadalajara University Hospital (Spain) between December 2008 and December 2009. Of these, 50.7%were morbidly obese and 49.3%were not obese. Fasting blood samples were taken from both groups for determination of 25-hydroxyvitamin D, intact parathyroid hormone, calcium, albumin and phosphorus, among other biochemical parameters.

Results

The mean concentration of 25-hydroxyvitamin D was 16.6卤8.12 ng/ml in the morbidly obese group and 21.9卤7.34 ng/ml in the non-obese group (p<0.0001). The prevalence of vitamin D deficiency was 80%in morbidly obese patients and 41%in non-obese patients (p<0.0001). There were no statistically significant differences in concentrations of parathyroid hormone, calcium or phosphorus between the two groups.

Conclusions

A high prevalence of vitamin D deficiency was found in both groups studied, although the concentration of 25-hydroxyvitamin D was significantly lower in the morbidly obese. Morbid obesity is closely linked to vitamin D deficiency. To prevent this deficiency, determination of 25-hydroxyvitamin D should be included in clinical practice guidelines for the treatment of obesity.